Class III · Low riskTerminated Initiated Jan 7, 2022 (5 years ago)
Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg, packaged in cartons…
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Why it was recalled
Mislabeling
What was recalled
Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx Only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured For: Teva Pharmaceuticals USA Inc. North Wales, PA 19454, NDC 0093-5455-42
Recalling firm
Teva Pharmaceuticals USA
NDC code
0093-5455-42
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0522-2022
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.